Open label trials are susceptible to bias through placebo effects. (en.hdbuzz.net)
All the subjects of the study are now on what's called an «open label extension» - those on placebo have been moved to drug and will continue to be monitored. (twitter.com)
The studies were completely open label, so both patients and clinicians knew of the desired result. (neurofantastic.com)